Congressional Research Service Reports - 563 Matching Results
Search Results
- Science and Technology Issues in the 113th Congress
- Report that briefly outlines an array of science and technology policy issues that may come before the 113th Congress.
- Science and Technology Issues in the 115th Congress
- This report briefly outlines an array of science and technology (S&T) policy issues that may come before the 115th Congress. Given the rapid pace of S&T advancement and its importance in many diverse public policy issues, S&T-related issues not discussed in this report may come before the 115th Congress. The selected issues are grouped into 9 categories: Overarching S&T Policy Issues, Agriculture, Biomedical Research and Development, Defense, Energy, Environment and Natural Resources, Homeland Security, Information Technology, Physical and Material Sciences, and Space. Each of these categories includes concise analysis of multiple policy issues. The material presented in this report should be viewed as illustrative rather than comprehensive. Each section identifies CRS reports, when available, and the appropriate CRS experts to contact for further information and analysis.
- Science and Technology Issues in the 115th Congress
- This report briefly outlines an array of science and technology (S&T) policy issues that may come before the 115th Congress. It breaks down selected issues into nine categories: overarching issues, agriculture, biomedical research and development, defense, energy, environment and natural resources, homeland security, information technology, physical and material sciences, and space.
- Science and Technology Policy: Issues for the 109th Congress
- Science and technology have a pervasive influence over a wide range of issues confronting the nation. Decisions on how much federal funding to invest in research and development (R&D) and determining what programs have the highest priority, for example, may have implications for homeland security, new high technology industries, government/private sector cooperation in R&D, and myriad other areas. This report indicates the sweep of science and technology in many public policy issues, such as global climate change, stem cell research, patent protection, and telecommunications reform. This report also addresses key issues that directly affect, or are affected by, science and technology.
- Science and Technology Policy: Issues for the 109th Congress
- No Description Available.
- Science and Technology Policy: Issues for the 109th Congress
- No Description Available.
- Oversight of High-Containment Biological Laboratories: Issues for Congress
- This report focuses on the federal government's regulation of high containment laboratories. It explains the concepts of biosecurity and biosafety, including the mechanisms by which the federal government oversees their implementation; describes the proliferation of high-containment laboratories; discusses issues facing federal policymakers; and identifies policy options for congressional consideration.
- Publishing Scientific Papers with Potential Security Risks: Issues for Congress
- This report describes the underlying controversy, the potential benefits and harms of publishing manuscripts with potential security risks, the actions taken by domestic and international stakeholders, and options that may improve the way research is handled to minimize security concerns.
- Rare Earth Elements in National Defense: Background, Oversight Issues, and Options for Congress
- This report covers concerns that Congress has expressed over U.S. acquisition of rare earth elements, particularly those used in various components of defense weapon systems. Specific concerns are the acquisition of these elements, especially from foreign sources such as China; how dependence of foreign sources affects national security; and methods for decreasing the relationship between reliance on foreign sources and national security.
- Animal Use in Research: Bibliography-in-Brief, 1985-87
- This bibliography deals with ethical and practical aspects of the use of animals in research and testing. It touches on animal right and some cases of practical alternatives to animal use.
- Animal Use in Research: Bibliography-in-Brief, 1985-87
- This bibliography deals with ethical and practical aspects of the use of animals in research and testing. It touches on animal rights and some cases of practical alternatives to animal use.
- Daylight Saving Time
- Currently, in most parts of the United States, timepieces are moved forward one hour in the spring and back one hour in the fall to provide an extended daylight period during the summer months. This is known as Daylight Saving Time (DST). Much debate and many changes led to this present practice. This report provides a brief history of the issues surrounding DST, an outline of the legislation that created and modified it, and a list of references to more discussions.
- Other Transaction (OT) Authority
- An "other transaction" (OT) is a special vehicle used by federal agencies for obtaining or advancing research and development (R&D) or prototypes. Generally, the reason for creating OT authority is that the government needs to obtain leading-edge R&D (and prototypes) from commercial sources, but some companies (and other entities) are unwilling or unable to comply with the government's procurement regulations. Evaluating OTs and the use of OT authority is a challenging undertaking. This report describes the issue of OT authority as it relates to Congressional policymaking and regulatory actions.
- Other Transaction (OT) Authority
- An other transaction (OT) is a special vehicle used by federal agencies for obtaining or advancing research and development (R&D) or prototypes. An OT is not a contract, grant, or cooperative agreement, and there is no statutory or regulatory definition of "other transaction." Only those agencies that have been provided OT authority may engage in other transactions.
- Other Transaction (OT) Authority
- This report discusses other transactions (OTs) which are special vehicles used by federal agencies for obtaining or advancing research and development (R&D) or prototypes. An OT is not a contract, grant, or cooperative agreement, and there is no statutory or regulatory definition of "other transaction." Only those agencies that have been provided OT authority may engage in other transactions.
- The National Science Foundation: Fiscal Year 2018 Appropriations and Funding History
- This report describes selected items from the Trump Administration's FY2018 budget request for the National Science Foundation (NSF) and tracks legislative action on FY2018 appropriations to the agency. It also details selected measures proposed in the 115th Congress to authorize increases in NSF appropriations limits and presents information on historical funding for the agency.
- The National Science Foundation: Fiscal Year 2018 Appropriations and Funding History
- This report outlines the National Science Foundation's 2017 fiscal year appropriations request and compares it with past years.The Trump Administration is seeking $6.653 billion for NSF in FY2018, an $819 million decrease (-11%) from the FY2017 enacted level of $7.472 billion.
- The President's Fiscal Year 2018 Budget Request for the National Science Foundation
- This report discuses the Trump Administration's 2018 fiscal year budget request for the National Science Foundation which proposed significant funding cuts across the agency's major research, education, and construction accounts. Overall, the request includes $6.653 billion for NSF, $819 million (11%) below the FY2017 enacted amount of $7.472 billion (P.L. 115-31).
- Federally Funded Academic Research Requirements: Background and Issues in Brief
- This report contains background information and selected issues on federal regulations and administrative requirements related to federally-funded academic research, including a general overview and discussion of select issues.
- NASA's Earth Science Enterprise
- No Description Available.
- Rare Earth Elements: The Global Supply Chain
- This report provides a discussion of the major issues and concerns of the global supply chain for rare earth elements (REEs), their major end uses, and legislative and other policy proposals that Congress may consider to improve the U.S. rare earth position.
- Rare Earth Elements: The Global Supply Chain
- The concentration of production of rare earth elements (REEs) outside the United States raises the important issue of supply vulnerability. REEs are used for new energy technologies and national security applications. This report provides a discussion on the major issues and concerns of the global supply chain for rare earth elements, their major end uses, and legislative and other policy proposals that Congress may consider to improve the U.S. rare earth position.
- Rare Earth Elements: The Global Supply Chain
- This report provides a discussion on the major issues and concerns of the global supply chain for rare earth elements, their major end uses, and legislative and other policy proposals that Congress may consider to improve the U.S. rare earth position. The concentration of production of rare earth elements (REEs) outside the United States raises the important issue of supply vulnerability, since they are used for new energy technologies and national security applications.
- Rare Earth Elements: The Global Supply Chain
- This report provides a discussion on the major issues and concerns of the global supply chain for rare earth elements, their major end uses, and legislative and other policy proposals that Congress may consider to improve the U.S. rare earth position.
- Overview of FY2017 Appropriations for Commerce, Justice, Science, and Related Agencies (CJS)
- This report tracks and describes actions taken by the Administration and Congress to provide FY2017 appropriations for the Commerce, Justice, Science, and Related Agencies (CJS) accounts. It also provides an overview of FY2016 appropriations for agencies and bureaus funded as part of annual CJS appropriations.
- Commerce, Justice, Science, and Related Agencies: FY2010 Appropriations
- This report provides an overview of actions taken by Congress to provide FY2011 appropriations for Commerce, Justice, Science, and Related Agencies (CJS). It also provides an overview of FY2010 appropriations for agencies and bureaus funded under the CJS bill.
- Commerce, Justice, Science, and Related Agencies: FY2011 Appropriations
- This report provides an overview of actions taken by Congress to provide FY2011 appropriations for Commerce, Justice, Science, and Related Agencies (CJS). It also provides an overview of FY2010 appropriations for agencies and bureaus funded under the CJS bill.
- Commerce, Justice, Science, and Related Agencies: FY2011 Appropriations
- This report provides an overview of actions taken by Congress to provide FY2011 appropriations for Commerce, Justice, Science, and Related Agencies (CJS). It also provides an overview of FY2010 appropriations for agencies and bureaus funded under the CJS bill.
- Biotechnology: Commercialization of Academic Research
- This report provides an overview of the commercialization of academic research h in the field of biotechnology. It offers a brief definition, background and policy analysis, as well as legislation and hearings regarding the topic.
- Cancer Research: Selected Federal Spending and Morbidity and Mortality Statistics
- This report shows federal spending at the National Institutes of Health (NIH) for research on selected cancer sites.
- Disease Funding and NIH Priority Setting
- Research at the National Institutes of Health (NIH) has strong political support, but a heated debate rages over the allocation of NIH funds among various diseases. NIH contends that decisions are made based on scientific opportunity while critics of the NIH process charge that spending often follows current politics and political correctness.
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- This report provides background on the research and potential applications of research that uses embryonic and adult stem cells. It also provides information about the current federal and state regulatory landscape, related Congressional and international actions, and relevant ethical concerns.
- Stem Cell Research
- This report provides background on the research and potential applications of research that uses embryonic and adult stem cells. It also provides information about the current federal and state regulatory landscape, related Congressional and international actions, and relevant ethical concerns.
- Stem Cell Research
- Embryonic stem cells have the ability to develop into virtually any cell in the body, and they may have the potential to treat medical conditions such as diabetes and Parkinson’s disease. In August 2001, President Bush announced that for the first time federal funds would be used to support research on human embryonic stem cells, but funding would be limited to “existing stem cell lines.” The National Institutes of Health (NIH) has established the Human Embryonic Stem Cell Registry, which lists 78 stem cell lines that are eligible for use in federally funded research. However, only 22 embryonic stem cell lines are currently available. Scientists are concerned about the quality, and longevity of these stem cell lines.
- Stem Cell Research
- Embryonic stem cells have the ability to develop into virtually any cell in the body and they may have the potential to treat medical conditions such as diabetes and Parkinson’s disease. In August 2001, President Bush announced that for the first time federal funds would be used to support research on human embryonic stem cells, but funding would be limited to “existing stem cell lines.”
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- No Description Available.
- Stem Cell Research
- No Description Available.
- H.R. 6: The 21st Century Cures Act
- Report about H.R. 6, the 21st Century Cures Act, which would reauthorize the National Institutes of Health (NIH) through FY2018 and provide other funding to the agency through FY2020.
- The Genetic Information Nondiscrimination Act of 2008 (GINA)
- This report provides background on genetic information, legal implications regarding the use of this information, and relevant laws. It also discusses the statutory provisions of the Genetic Information Nondiscrimination Act of 2008 (GINA).
- Financing Catastrophic Risk: Summary of the Homeowners' Defense Act of 2009 (S. 505 and H.R. 2555)
- This report discusses the drastic increase in demand for homeowners' insurance in Atlantic and Gulf Coast states following the devastation of Hurricane Katrina in 2005. This report also discusses various measures and efforts underway to enhance insurer capacity, pursue alternative forms of risk transfer, and create a national catastrophe financing facility, the last of which is an issue under considerable debate.
- Social Science Policies: An Annotated List of Recent Literature
- This report is a bibliography created to update the Congressional Research Service multilith, "The Social Sciences and Public Policy: A Selected, Annotated Bibliography."
- Counterterrorism Research and Development: Funding, Priority-setting, and Coordination
- This report describes the basic R&D issues that concern the adequacy of planning/coordination mechanisms, including those in the Office of Science and Technology Policy and Office of Homeland Security; which counterterrorism R&D should be transferred to a new department; and how other R&D counterterrorism activities that are not transferred should be coordinated.